---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-027544"
form_type: "8-K"
ticker: "CELC"
cik: "0001603454"
company_name: "Celcuity Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T17:38:00.312674+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Celcuity Q2 net loss $14.6M; Phase 1b gedatolisib data shows 48.6-month median PFS

## Summary
- Net loss $14.6M ($0.66/share) vs $10.0M ($0.67) Q2 2022; non-GAAP adjusted net loss $12.8M.
- Cash, equivalents and short-term investments $146.2M at June 30; R&D $13.7M, up $5.4M on VIKTORIA-1.
- Phase 3 VIKTORIA-1 on track; recruiting at ~200 sites in 20 countries; PIK3CA wild-type data H2 2024, mutant H1 2025.
- Updated Phase 1b gedatolisib combo: median PFS 48.6 months, ORR 79% in 41 treatment-naïve HR+/HER2- advanced breast cancer patients.

## SEC filing metadata
- accession: 0001493152-23-027544
- form_type: 8-K
- ticker: CELC
- cik: 0001603454
- company_name: Celcuity Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603454/000149315223027544/0001493152-23-027544-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603454/000149315223027544/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-027544
- JSON: https://secwatch.observer/filing/0001493152-23-027544.json
- Plain text: https://secwatch.observer/filing/0001493152-23-027544.txt

## Key facts
- Earnings Releases
  Celcuity Inc. reported second quarter ended June 30, 2023 results: net income $14.6 million, or $0.66 loss per share, EPS $0.66 loss per share.
  - Period: second quarter ended June 30, 2023
  - Net income: $14.6 million, or $0.66 loss per share
  - EPS: $0.66 loss per share
  - Result: reported results
  source text: Net loss for the second quarter of 2023 was $14.6 million, or $0.66 loss per share, compared to a net loss of $10.0 million, or $0.67 loss per share, for the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603454/000149315223027544/0001493152-23-027544-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.